TECH MEXC RealStocks
Own real TECH shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 02:27:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Bio-Techne Corp. (TECH) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $72.75, with a market capitalization of $11.43B and a P/E ratio of 66.35. Over the past 52 weeks, its price has ranged from $43.20 to $72.88. This page covers its latest market performance, valuation, price trends and company information.
$11.43B | |
$72.67 | |
$72.81 | |
$72.53 | |
$72.63 | |
2.36M | |
2.92M | |
66.35 | |
$72.88 | |
$43.20 | |
0.44% | |
2026-09-30 |
Bio-Techne Corp. (TECH) last closed at $72.75 as of 2026-11-19 00:31:00, up 0.15% ($0.11) from the previous close of $72.63.
During the latest regular trading session, TECH traded between $72.53 and $72.81, with a volume of 2.36M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Bio-Techne Corp. (TECH) moved from $72.83 to $72.75, representing a decline of 0.12% ($0.08).
The stock traded between $72.53 and $72.88 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 3.40 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 99.5%
TECH is currently trading at $72.75, placing it 99.5% of the way from its 52-week low of $43.20 to its 52-week high of $72.88. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 3,000 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Bio-Techne Corp.
Dividend | |
|---|---|
| Ex-Dividend Date | Nov 13, 2026 |
| Payment Date | Nov 23, 2026 |
| Dividend Per Share | $0.08 |
Eligible investors can buy real shares of Bio-Techne Corp. (TECH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to TECH, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between TECH shares and USD.
TECH Shares to USD
1.00 TECH shares = 72.745 USD
Calculations are estimates based on the latest available price and are for reference only.